Certara, Inc. (CERT)

NASDAQ: CERT · IEX Real-Time Price · USD
17.96
+0.33 (1.90%)
Mar 28, 2024, 2:39 PM EDT - Market open

Company Description

Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally.

It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.

The company provides Simcyp Simulator, a mechanistic biosimulation platform mechanistic biosimulation investigational new drug and translational stages; Simcyp Biopharmaceutics, used to identify and refine drug formulations; and Simcyp Secondary Intelligence which integrates toxicology with quantitative analysis of networks of molecular and functional biological changes to identify drug toxicity and adverse drug reactions.

In addition, it offers Phoenix WinNonlin, a platform for non-compartmental analysis, pharmacokinetic/pharmacodynamic, and toxicokinetic; phoenix hosted, that provides a secured and validated certara amazon web services workspace; Phoenix NLME, a population modeling and simulation software for nonlinear mixed effects models; and pirana modeling workbench.

Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange, used to define data standards and specifications; and Metadata Repository, to enable study design using controlled and standardized data.

It serves life sciences companies, biopharmaceutical companies, research organizations, academic institutions, and global regulators, as well as animal health, crop science, bio science, medical devices, and public sector industries.

Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.

Certara, Inc.
Certara logo
Country United States
Founded 2008
IPO Date Dec 11, 2020
Industry Health Information Services
Sector Healthcare
Employees 1,391
CEO Dr. William F. Feehery Ph.D.

Contact Details

Address:
100 Overlook Center, Suite 101
Princeton, New Jersey 08540
United States
Phone (609) 716-7900
Website certara.com

Stock Details

Ticker Symbol CERT
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $23.00
CIK Code 0001827090
CUSIP Number 15687V109
ISIN Number US15687V1098
SIC Code 7372

Key Executives

Name Position
Dr. William F. Feehery Ph.D. Chief Executive Officer and Director
Leif E. Pedersen President and Chief Commercial Officer
Dr. Robert P. Aspbury Ph.D. President of Certara Scientific Software
Dr. Patrick F. Smith Pharm.D. President of Certara Drug Development Solutions
John E. Gallagher III Chief Financial Officer
Max Kanevsky Chief Technology Officer
Prof. Amin Rostami PharmD, Ph.D., FCP Chief Scientific Officer
Richard M. Traynor Senior Vice President, General Counsel and Secretary
Ron DiSantis Senior Vice President of Corporate Development
Sheila Rocchio MBA Chief Marketing Officer

Latest SEC Filings

Date Type Title
Mar 27, 2024 D Notice of Exempt Offering of Securities
Mar 4, 2024 144 Filing
Feb 29, 2024 10-K Annual Report
Feb 29, 2024 8-K Current Report
Feb 20, 2024 144 Filing
Feb 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2024 144 Filing
Jan 30, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Jan 25, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Dec 26, 2023 144 Filing